LOTRIDERM

This brand name is authorized in Canada, Ecuador, Poland, United Kingdom, South Africa

Active ingredients

The drug LOTRIDERM contains a combination of these active pharmaceutical ingredients (APIs):

1 Clotrimazole UNII G07GZ97H65 - CLOTRIMAZOLE

Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc. Read about Clotrimazole

2 Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. Read about Betamethasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LOTRIDERM Cream	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D01AC20	Combinations	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00611174
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 367460813
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 143687, 162028, 175730, 185904, 28995
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100084749
Country: ZA	Health Products Regulatory Authority	Identifier(s): R/13.4.1/38